Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-11

Clinical Trial Update: Pulmonary Gas Exchange Response to Indacaterol in COPD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on indacaterol evaluating its effects on pulmonary gas exchange in chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indacaterol (Arcapta Neohaler) (Indacaterol)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: UNKNOWN